Toby Garrood

Therapeutic benefit of blocking interleukin‐6 activity with an anti–interleukin‐6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double‐blind, placebo‐controlled, dose‐escalation trial

Ernest Choy, David Isenberg, Toby Garrood et al. · Arthritis & Rheumatism · 2002 · 535 citations

Life Sciences, Immunology, Pharmacotherapy +15

Interleukin‐17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression

Bina Menon, Nicola Gullick, Gina Walter et al. · Arthritis & Rheumatology · 2014 · 287 citations · Full text

Life Sciences, Immunology, Autoimmunity +16

Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial

Andrew P. Cope, Marianna Jasenecova, Joana C. Vasconcelos et al. · The Lancet · 2024 · 160 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Hydroxychloroquine Effectiveness in Reducing Symptoms of Hand Osteoarthritis

Sarah R. Kingsbury, Puvan Tharmanathan, Ada Keding et al. · Annals of Internal Medicine · 2018 · 91 citations · Full text

Medicine, Orthopaedic Surgery, Pharmacotherapy +17

Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes

Katie Bechman, Lieke Tweehuysen, Toby Garrood et al. · The Journal of Rheumatology · 2018 · 65 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17